Hafford was not the only trial recruit to suffer. In the initial Phase I trial on twenty-one pregnant women, NIAID’s investigators would later report that four of twenty-two infants died and twelve suffered “serious adverse events.” Furthermore, the studies suggested that Nevirapine was ineffective. None of the women experienced reduction of viral loads.
